Just 10 drugs accounted for 63 percent of the wasted money, as reported by Axios.
Velcade, a chemotherapy drug designed to treat myeloma and mantle cell lymphoma made by Takeda Pharmaceutical, was the most wasted drug, costing Medicare $123 million.
NPlate, a bone marrow stimulant made by Amgen, cost Medicare $78 million.
Find the full data here.
More articles on pharmacy:
Novo Nordisk selling authorized generics of insulin at 50% discount
New Year’s Day drug price hikes hit more than 250 meds
Aurobindo Pharma recalls antidepressant with mislabeled dosage
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.